Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$44,650,401
+$42,954,479 QoQ
Shares Held
1,764,838
+2216.5% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#16
of 354 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. ACAD ranks #20 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in ACAD
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,650,401 | 1,764,838 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $1,695,922 | 76,187 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $13,178,153 | 493,379 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $50,338,520 | 2,358,881 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $42,486,665 | 1,969,711 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $5,487,877 | 330,396 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $18,232,431 | 993,593 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $18,280,852 | 1,188,612 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $45,083,236 | 2,774,353 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $9,659,415 | 522,413 | Shares | Other | 2024-05-15 | |
| 2023-09-30 | $19,626,173 | 941,755 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $595,205 | 24,852 | Shares | Other | 2023-08-14 | |
| 2022-03-31 | $12,898,529 | 532,557 | Shares | Other | 2022-05-16 | |
| 2020-12-31 | $45,370,379 | 848,679 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $46,769,745 | 1,133,812 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,700,107 | 200,126 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||